Hydrogen sulphide reduced the accumulation of lipid droplets in cardiac tissues of db/db mice via Hrd1 S-sulfhydration

J Cell Mol Med. 2021 Oct;25(19):9154-9167. doi: 10.1111/jcmm.16781. Epub 2021 Sep 25.

Abstract

Accumulation of lipid droplets (LDs) induces cardiac dysfunctions in type 2 diabetes patients. Recent studies have shown that hydrogen sulphide (H2 S) ameliorates cardiac functions in db/db mice, but its regulation on the formation of LDs in cardiac tissues is unclear. Db/db mice were injected with NaHS (40 μmol·kg-1 ) for twelve weeks. H9c2 cells were treated with high glucose (40 mmol/L), oleate (200 µmol/L), palmitate (200 µmol/L) and NaHS (100 µmol/L) for 48 hours. Plasmids for the overexpression of wild-type Hrd1 and Hrd1 mutated at Cys115 were constructed. The interaction between Hrd1 and DGAT1 and DGAT2, the ubiquitylation level of DGAT1 and 2, the S-sulfhydration of Hrd1 were measured. Exogenous H2 S ameliorated the cardiac functions, decreased ER stress and reduced the number of LDs in db/db mice. Exogenous H2 S could elevate the ubiquitination level of DGAT 1 and 2 and increased the expression of Hrd1 in cardiac tissues of db/db mice. The S-sulfhydration of Hrd1 by NaHS enhanced the interaction between Hrd1 and DGAT1 and 2 to inhibit the formation of LD. Our findings suggested that H2 S modified Hrd1 S-sulfhydration at Cys115 to reduce the accumulation of LDs in cardiac tissues of db/db mice.

Keywords: DGAT; Hrd1; Lipid droplets; S-sulfhydration; diabetic cardiomyopathy; hydrogen sulphide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers
  • Diabetes Mellitus, Type 2
  • Diabetic Cardiomyopathies / diagnosis
  • Diabetic Cardiomyopathies / etiology
  • Diabetic Cardiomyopathies / metabolism
  • Diabetic Cardiomyopathies / physiopathology
  • Disease Models, Animal
  • Echocardiography
  • Female
  • Heart Function Tests
  • Hydrogen Sulfide / pharmacology*
  • Hyperglycemia
  • Hyperlipidemias
  • Lipid Droplets / metabolism*
  • Lipid Metabolism / drug effects*
  • Male
  • Mice
  • Mice, Knockout
  • Models, Biological
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / ultrastructure
  • Protein Processing, Post-Translational
  • Proteome
  • Proteomics / methods
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism*

Substances

  • Biomarkers
  • Proteome
  • Syvn1 protein, mouse
  • Ubiquitin-Protein Ligases
  • Hydrogen Sulfide